Background: To know the prevalence of phenotypic dyslipidemias and their clinical and metabolic characteristics in recently diagnosed hypertensive patients.
Methods: Consecutive study of 158 essential hypertensive patients without previous pharmacological treatment.
Results: 69.6% of the patients had some kind of dyslipidemia, being the isolated increase of Lp(a) (27.3%) the most prevalent and the hyperapobetalipoproteinemia the less (10.0%). Age, sex, smoking, alcohol consumption, uric acid, systolic and pulse pressure and serum glucose were different among phenotypes.
Conclusions: Essential hypertensive patients have high and heterogeneous prevalence of dyslipidemias.